Greenlee; William J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Greenlee; William J..The latest application filed is for "progranulin modulators and methods of using the same".
Company Profile
4.119.91
- Greenlee; William J. - Teaneck NJ
- Greenlee; William J - Teaneck NJ
Patent Activity
| Patent | Date |
|---|---|
| Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders Grant 11,453,675 - Skerlj , et al. September 27, 2 | 2022-09-27 |
| Progranulin Modulators And Methods Of Using The Same App 20220251084 - Burnett; Duane A. ; et al. | 2022-08-11 |
| SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS App 20220185814 - Skerlj; Renato T. ; et al. | 2022-06-16 |
| Inhibitors Of Gli1 As Therapeutic Agents App 20220009935 - GREENLEE; William J. ; et al. | 2022-01-13 |
| Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders Grant 11,168,087 - Skerlj , et al. November 9, 2 | 2021-11-09 |
| IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS App 20210309661 - Skerlj; Renato T. ; et al. | 2021-10-07 |
| Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders Grant 11,124,516 - Skerlj , et al. September 21, 2 | 2021-09-21 |
| Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders Grant 10,787,454 - Skerlj , et al. September 29, 2 | 2020-09-29 |
| SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT App 20190389866 - Skerlj; Renato T. ; et al. | 2019-12-26 |
| Pyrrolo[1,2-a]pyrimidinyl Carboxamide Compounds And Their Use In The Treatment Of Medical Disorders App 20190315751 - Skerlj; Renato T. ; et al. | 2019-10-17 |
| IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS App 20190119283 - Skerlj; Renato T. ; et al. | 2019-04-25 |
| Bridged bicyclic piperidine derivatives and methods of use thereof Grant 9,409,918 - Harris , et al. August 9, 2 | 2016-08-09 |
| Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists Grant 9,340,530 - Mandal , et al. May 17, 2 | 2016-05-17 |
| Substituted biaryl derivatives and methods of use thereof Grant 9,301,929 - Boyle , et al. April 5, 2 | 2016-04-05 |
| Bridged and fused antidiabetic compounds Grant 9,278,965 - Josien , et al. March 8, 2 | 2016-03-08 |
| Heterocyclic Aspartyl Protease Inhibitors App 20150105354 - Zhu; Zhaoning ; et al. | 2015-04-16 |
| Morpholinone compounds as factor IXA inhibitors Grant 8,987,242 - Chackalamannil , et al. March 24, 2 | 2015-03-24 |
| Preparation And Use Of Bicyclic Himbacine Derivatives As Par-1 Receptor Antagonists App 20150025046 - Mandal; Mihir ; et al. | 2015-01-22 |
| Gamma secretase inhibitors Grant 8,933,116 - Wu , et al. January 13, 2 | 2015-01-13 |
| Pyrimidine ether derivatives and methods of use thereof Grant 8,912,206 - Neelamkavil , et al. December 16, 2 | 2014-12-16 |
| Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 Grant 8,907,095 - Xia , et al. December 9, 2 | 2014-12-09 |
| Heterocyclic aspartyl protease inhibitors Grant 8,829,036 - Zhu , et al. September 9, 2 | 2014-09-09 |
| Bicyclic heterocycle derivatives and use thereof as GPR119 modulators Grant 8,822,480 - Neelamkavil , et al. September 2, 2 | 2014-09-02 |
| Bicyclic heterocycle derivatives and methods of use thereof Grant 8,815,876 - Neelamkavil , et al. August 26, 2 | 2014-08-26 |
| Gamma secretase modulators Grant 8,809,318 - Zhu , et al. August 19, 2 | 2014-08-19 |
| Heterocyclic aspartyl protease inhibitors Grant 8,778,980 - Zhu , et al. July 15, 2 | 2014-07-15 |
| Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use Grant 8,735,604 - Gilbert , et al. May 27, 2 | 2014-05-27 |
| Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2 | 2014-04-08 |
| Heterocyclic aspartyl protease inhibitors Grant 8,691,833 - Zhu , et al. April 8, 2 | 2014-04-08 |
| Gamma secretase modulators Grant 8,673,900 - Zhu , et al. March 18, 2 | 2014-03-18 |
| Heterocyclic Aspartyl Protease Inhibitors App 20140057910 - Zhu; Zhaoning ; et al. | 2014-02-27 |
| Bridged And Fused Antidiabetic Compounds App 20140038970 - JOSIEN; HUBERT B. ; et al. | 2014-02-06 |
| Morpholinone compounds as factor IXa inhibitors Grant 8,642,582 - Nishida , et al. February 4, 2 | 2014-02-04 |
| Gamma Secretase Inhibitors App 20140018342 - Wu; Wen-Lian ; et al. | 2014-01-16 |
| Substituted piperazines as CB1 antagonists Grant 8,623,873 - Gilbert , et al. January 7, 2 | 2014-01-07 |
| Glucagon receptor antagonists, compositions, and methods for their use Grant 8,623,818 - Greenlee , et al. January 7, 2 | 2014-01-07 |
| 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors Grant 8,609,676 - Chelliah , et al. December 17, 2 | 2013-12-17 |
| Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders Grant 8,580,807 - Boyle , et al. November 12, 2 | 2013-11-12 |
| Gamma secretase modulators Grant 8,580,956 - Zhu , et al. November 12, 2 | 2013-11-12 |
| Gamma secretase modulators Grant 8,518,975 - Aslanian , et al. August 27, 2 | 2013-08-27 |
| Gamma secretase modulators Grant 8,487,099 - Greenlee , et al. July 16, 2 | 2013-07-16 |
| Thiophenes as glucagon receptor antagonists, compositions, and methods for their use Grant 8,470,773 - Gilbert , et al. June 25, 2 | 2013-06-25 |
| Adenosine A.sub.2a receptor antagonists Grant RE44,205 - Neustadt , et al. May 7, 2 | 2013-05-07 |
| Gamma secretase modulators Grant 8,426,403 - Zhu , et al. April 23, 2 | 2013-04-23 |
| Substituted Piperazines As Cb1 Antagonists App 20130072468 - Gilbert; Eric J. ; et al. | 2013-03-21 |
| Spiro-imidazolone derivatives as glucagon receptor antagonists Grant 8,361,959 - Stamford , et al. January 29, 2 | 2013-01-29 |
| Gamma secretase modulators Grant 8,357,682 - Zhu , et al. January 22, 2 | 2013-01-22 |
| Heterocyclic Aspartyl Protease Inhibitors App 20130018066 - Zhu; Zhaoning ; et al. | 2013-01-17 |
| Novel Spiro Imidazolone Derivatives As Glucagon Receptor Antagonists, Compositions, And Methods For Their Use App 20130012493 - Zhao; He ; et al. | 2013-01-10 |
| Novel Spiro Imidazolones As Glucagon Receptor Antagonists, Compositions, And Methods For Their Use App 20130012434 - Wong; Michael K. ; et al. | 2013-01-10 |
| Pyrimidine Ether Derivatives And Methods Of Use Thereof App 20120289525 - Neelamkavil; Santhosh Francis ; et al. | 2012-11-15 |
| Heterocyclic Aspartyl Protease Inhibitors App 20120276118 - Zhu; Zhaoning ; et al. | 2012-11-01 |
| Gamma Secretase Modulators App 20120245158 - Huang; Xianhai ; et al. | 2012-09-27 |
| Gamma Secretase Modulators App 20120238546 - Zhu; Zhaoning ; et al. | 2012-09-20 |
| Gamma Secretase Modulators App 20120232108 - Huang; Xianhai ; et al. | 2012-09-13 |
| Heterocyclic Aspartyl Protease Inhibitors App 20120231017 - ZHU; ZHAONING ; et al. | 2012-09-13 |
| Heterocyclic Aspartyl Protease Inhibitors App 20120231018 - Zhu; Zhaoning ; et al. | 2012-09-13 |
| Substituted Biaryl Derivatives And Methods Of Use Thereof App 20120220614 - Boyle; Craig D. ; et al. | 2012-08-30 |
| Bridged Bicyclic Piperidine Derivatives And Methods Of Use Thereof App 20120214805 - Harris; Joel M. ; et al. | 2012-08-23 |
| Heterocyclic aspartyl protease inhibitors Grant 8,242,112 - Zhu , et al. August 14, 2 | 2012-08-14 |
| Substituted piperazines as CB.sub.1 antagonists Grant 8,236,805 - Gilbert , et al. August 7, 2 | 2012-08-07 |
| Novel Pyrrolidines As Glucagon Receptor Antagonists, Compositions, And Methods For Their Use App 20120178789 - Gilbert; Eric J. ; et al. | 2012-07-12 |
| 4, 5, 6-trisubstituted Pyrimidine Derivatives As Factor Ixa Inhibitors App 20120136016 - Chelliah; Mariappan V. ; et al. | 2012-05-31 |
| Gamma Secretase Modulators App 20120129846 - Zhu; Zhaoning ; et al. | 2012-05-24 |
| Heterocyclic aspartyl protease inhibitors Grant 8,183,252 - Zhu , et al. May 22, 2 | 2012-05-22 |
| Heterocyclic aspartyl protease inhibitors Grant 8,178,513 - Zhu , et al. May 15, 2 | 2012-05-15 |
| Gamma Secretase Modulators App 20120107328 - Greenlee; William J. ; et al. | 2012-05-03 |
| Thiophenes As Glucagon Receptor Antagonists, Compositions, And Methods For Their Use App 20120108505 - Gilbert; Eric J. ; et al. | 2012-05-03 |
| Heterocyclic compounds as factor IXA inhibitors Grant 8,148,363 - Clasby , et al. April 3, 2 | 2012-04-03 |
| Bicyclic Piperidine And Piperazine Derivatives As Gpcr Modulators For The Treatment Of Obesity, Diabetes And Other Metabolic Disorders App 20120021976 - Boyle; Craig D. ; et al. | 2012-01-26 |
| Pentafluorosulpholane-containing Antidiabetic Compounds App 20110313008 - Josien; Hubert B. ; et al. | 2011-12-22 |
| Bridged And Fused Antidiabetic Compounds App 20110312967 - Josien; Hubert B. ; et al. | 2011-12-22 |
| Bridged And Fused Heterocyclic Antidiabetic Compounds App 20110312995 - Josien; Hubert B. ; et al. | 2011-12-22 |
| Gamma Secretase Modulators App 20110306593 - Zhu; Zhaoning ; et al. | 2011-12-15 |
| Gamma Secretase Modulators App 20110257156 - Zhu; Zhaoning ; et al. | 2011-10-20 |
| Heterocyclic Aspartyl Protease Inhibitors App 20110218194 - Zhu; Zhaoning ; et al. | 2011-09-08 |
| Bicyclic Heterocycle Derivatives And Their Use As Modulators Of The Activity Of Gpr119 App 20110212938 - Xia; Yan ; et al. | 2011-09-01 |
| Spiro-imidazolone Derivatives As Glucagon Receptor Antagonists App 20110178007 - Stamford; Andrew ; et al. | 2011-07-21 |
| Bicyclic Heterocycle Derivatives And Use Thereof As Gpr119 Modulators App 20110166165 - Neelamkavil; Santhosh Francis ; et al. | 2011-07-07 |
| Bicyclic Heterocycle Derivatives And Methods Of Use Thereof App 20110166167 - Neelamkavil; Santhosh Francis ; et al. | 2011-07-07 |
| Heterocyclic aspartyl protease inhibitors Grant 7,973,067 - Zhu , et al. July 5, 2 | 2011-07-05 |
| Morpholinone Compounds As Factor Ixa Inhibitors App 20110135650 - CHACKALAMANNIL; Samuel ; et al. | 2011-06-09 |
| Gamma Secretase Modulators App 20110082153 - Aslanian; Robert G. ; et al. | 2011-04-07 |
| Heterocyclic Compounds As Factor Ixa Inhibitors App 20110065682 - Clasby; Martin C. ; et al. | 2011-03-17 |
| Glucagon Receptor Antagonists, Compositions, And Methods For Their Use App 20110065634 - Greenlee; William J. ; et al. | 2011-03-17 |
| Bicyclic Heterocycle Derivatives And Use Thereof As Gpr119 Modulators App 20110065671 - Harris; Joel M. ; et al. | 2011-03-17 |
| Morpholinone Compounds As Factor Ixa Inhibitors App 20110059958 - Nishida; Hidemitsu ; et al. | 2011-03-10 |
| Gamma Secretase Modulators App 20110053918 - Zhu; Zhaoning ; et al. | 2011-03-03 |
| Cannabinoid receptor modulators Grant 7,897,601 - Chackalamannil , et al. March 1, 2 | 2011-03-01 |
| Gamma Secretase Modulators For The Treatment Of Alzheimer's Disease App 20110027264 - Huang; Xianhai ; et al. | 2011-02-03 |
| Gamma Secretase Modulators App 20110009392 - Zhu; Zhaoning ; et al. | 2011-01-13 |
| Aspartyl protease inhibitors Grant 7,868,000 - Zhu , et al. January 11, 2 | 2011-01-11 |
| Gamma Secretase Modulators App 20100298381 - Zhu; Zhaoning ; et al. | 2010-11-25 |
| Heterocyclic Aspartyl Protease Inhibitors App 20100292203 - Zhu; Zhaoning ; et al. | 2010-11-18 |
| Substituted Piperazines As Cb1 Antagonists App 20100286160 - Gilbert; Eric J. ; et al. | 2010-11-11 |
| Gamma Secretase Modulators App 20100255005 - Zhu; Zhaoning ; et al. | 2010-10-07 |
| Gamma Secretase Modulators App 20100256128 - Zhu; Zhaoning ; et al. | 2010-10-07 |
| Gamma Secretase Modulators App 20100247514 - Zhu; Zhaoning ; et al. | 2010-09-30 |
| Substituted Piperazines As Cb1 Antagonists App 20100249144 - Demong; Duane Eugene ; et al. | 2010-09-30 |
| Heterocyclic aspartyl protease inhibitors Grant 7,763,609 - Zhu , et al. July 27, 2 | 2010-07-27 |
| Thrombin receptor antagonists Grant 7,713,999 - Chackalamannil , et al. May 11, 2 | 2010-05-11 |
| Heterocyclic aspartyl protease inhibitors Grant 7,700,603 - Zhu , et al. April 20, 2 | 2010-04-20 |
| Substituted piperazines as CB1 antagonists Grant 7,700,597 - Gilbert , et al. April 20, 2 | 2010-04-20 |
| Pyridothienopyridazinone derivatives as mGluR1 antagonists Grant 7,687,501 - Bennett , et al. March 30, 2 | 2010-03-30 |
| Substituted Piperazines as CB1 Antagonists App 20100029607 - Gilbert; Eric J. ; et al. | 2010-02-04 |
| Heterocyclic Aspartyl Protease Inhibitors App 20090306047 - Zhu; Zhaoning ; et al. | 2009-12-10 |
| Heterocyclic Aspartyl Protease Inhibitors App 20090258868 - Zhu; Zhaoning ; et al. | 2009-10-15 |
| Heterocyclic aspartyl protease inhibitors Grant 7,592,348 - Zhu , et al. September 22, 2 | 2009-09-22 |
| Substituted Piperazines as CB1 Antagonists App 20090105208 - Gilbert; Eric J. ; et al. | 2009-04-23 |
| 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders Grant 7,511,146 - Burnett , et al. March 31, 2 | 2009-03-31 |
| Selective D.sub.1/D.sub.5 receptor antagonists for the treatment of obesity and CNS disorders Grant 7,504,391 - Burnett , et al. March 17, 2 | 2009-03-17 |
| Neuropeptide receptor modulators Grant 7,459,450 - Zhu , et al. December 2, 2 | 2008-12-02 |
| Constrained himbacine analogs as thrombin receptor antagonists Grant 7,442,712 - Chelliah , et al. October 28, 2 | 2008-10-28 |
| Heterocyclic aspartyl protease inhibitors App 20080200445 - Zhu; Zhaoning ; et al. | 2008-08-21 |
| Thrombin receptor antagonists Grant 7,304,078 - Chackalamannil , et al. December 4, 2 | 2007-12-04 |
| Thrombin Receptor Antagonists App 20070270439 - Chackalamannil; Samuel ; et al. | 2007-11-22 |
| Tra Combination Therapies App 20070238674 - Veltri; Enrico P. ; et al. | 2007-10-11 |
| Crystalline Polymorph Of A Bisulfate Salt Of A Thrombin Receptor Antagonist App 20070203193 - Thiruvengadam; Tiruvettipuram K. ; et al. | 2007-08-30 |
| Diaryl piperidines as CB1 modulators App 20070203183 - Scott; Jack D. ; et al. | 2007-08-30 |
| Cannabinoid receptor modulators App 20070197628 - Chackalamannil; Samuel ; et al. | 2007-08-23 |
| Thrombin Receptor Antagonists App 20070179187 - Chackalamannil; Samuel ; et al. | 2007-08-02 |
| Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders Grant 7,211,574 - Wu , et al. May 1, 2 | 2007-05-01 |
| Fused tricyclic mGIuR1 antagonists as therapeutic agents App 20070072864 - Bennett; Chad E. ; et al. | 2007-03-29 |
| Heterocyclic aspartyl protease inhibitors App 20070072852 - Zhu; Zhaoning ; et al. | 2007-03-29 |
| Aspartyl protease inhibitors App 20070060575 - Zhu; Zhaoning ; et al. | 2007-03-15 |
| Substituted piperazines as CB1 antagonists App 20060241121 - Greenlee; William J. ; et al. | 2006-10-26 |
| Heterocyclic aspartyl protease inhibitors App 20060111370 - Zhu; Zhaoning ; et al. | 2006-05-25 |
| Neuropeptide receptor modulators App 20060089351 - Zhu; Zhaoning ; et al. | 2006-04-27 |
| Constrained himbacine analogs as thrombin receptor antagonists App 20050267155 - Chelliah, Mariappan V. ; et al. | 2005-12-01 |
| Adenosine A2a receptor antagonists Grant 6,916,811 - Boyle , et al. July 12, 2 | 2005-07-12 |
| Adenosine A2a receptor antagonists Grant 6,897,216 - Neustadt , et al. May 24, 2 | 2005-05-24 |
| Substituted urea neuropeptide Y Y5 Receptor antagonists Grant 6,894,063 - Greenlee , et al. May 17, 2 | 2005-05-17 |
| Muscarinic antagonists Grant 6,890,936 - Boyle , et al. May 10, 2 | 2005-05-10 |
| Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders App 20050075325 - Burnett, Duane A. ; et al. | 2005-04-07 |
| 2-Substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders App 20050054628 - Burnett, Duane A. ; et al. | 2005-03-10 |
| Substituted urea neuropeptide Y Y5 receptor antagonists App 20050038100 - Greenlee, William J. ; et al. | 2005-02-17 |
| Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist App 20040176418 - Thiruvengadam, Tiruvettipuram K. ; et al. | 2004-09-09 |
| Muscarinic antagonists App 20040067972 - Boyle, Craig D. ; et al. | 2004-04-08 |
| Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders App 20040058906 - Wu, Wen-Lian ; et al. | 2004-03-25 |
| Adenosine A2a receptor antagonists App 20040023997 - Neustadt, Bernard R. ; et al. | 2004-02-05 |
| Thrombin receptor antagonists App 20030216437 - Chackalamannil, Samuel ; et al. | 2003-11-20 |
| Adenosine A2a receptor antagonists App 20030212059 - Boyle, Craig D. ; et al. | 2003-11-13 |
| Adenosine A2a receptor antagonists Grant 6,630,475 - Neustadt , et al. October 7, 2 | 2003-10-07 |
| Substituted urea neuropeptide Y Y5 receptor antagonists App 20030114517 - Greenlee, William J. ; et al. | 2003-06-19 |
| Substituted urea neuropeptide Y Y5 receptor antagonists App 20020165223 - Greenlee, William J. ; et al. | 2002-11-07 |
| Adenosine A2a receptor antagonists App 20020099061 - Neustadt, Bernard R. ; et al. | 2002-07-25 |
| Phenoxyphenylacetic acid derivatives Grant 5,668,176 - Bagley , et al. September 16, 1 | 1997-09-16 |
| Biphenyl compounds useful or endothelin antagonists Grant 5,565,485 - Bagley , et al. October 15, 1 | 1996-10-15 |
| Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists Grant 5,411,980 - Ashton , et al. May 2, 1 | 1995-05-02 |
| Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists Grant 5,412,097 - Chakravarty , et al. May 2, 1 | 1995-05-02 |
| Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists Grant 5,389,660 - Greenlee , et al. February 14, 1 | 1995-02-14 |
| Disubstituted 6-aminoquinazolinones Grant 5,385,894 - de Laszlo , et al. January 31, 1 | 1995-01-31 |
| Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives Grant 5,334,598 - Bagley , et al. August 2, 1 | 1994-08-02 |
| Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists Grant 5,332,744 - Chakravarty , et al. July 26, 1 | 1994-07-26 |
| Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists Grant 5,330,987 - Allen , et al. July 19, 1 | 1994-07-19 |
| Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines Grant 5,312,820 - Ashton , et al. May 17, 1 | 1994-05-17 |
| N,N-diacylpiperazines Grant 5,292,726 - Ashton , et al. March 8, 1 | 1994-03-08 |
| Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists Grant 5,281,614 - Ashton , et al. January 25, 1 | 1994-01-25 |
| Substituted pyrazoles, compositions and use Grant 5,262,412 - Ashton , et al. November 16, 1 | 1993-11-16 |
| Substituted pyrazolopyrimidines as angiotensin II antagonists Grant 5,250,521 - Allen , et al. October 5, 1 | 1993-10-05 |
| Substituted quinazolinones as angiotensin II antagonists Grant 5,240,928 - Allen , et al. August 31, 1 | 1993-08-31 |
| Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists Grant 5,238,942 - Chakravarty , et al. August 24, 1 | 1993-08-24 |
| 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists Grant 5,223,499 - Greenlee , et al. June 29, 1 | 1993-06-29 |
| Substituted pyrimidinones bearing acidic functional groups as angiotensin II antagonists Grant 5,223,501 - Chakravarty , et al. * June 29, 1 | 1993-06-29 |
| Substituted fused pyrimidinones Grant 5,202,328 - de Laszlo , et al. April 13, 1 | 1993-04-13 |
| Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole Grant 5,187,159 - Greenlee , et al. February 16, 1 | 1993-02-16 |
| Imidazole angiotensin II antagonists incorporating a substituted benzyl element Grant 5,183,810 - Greenlee , et al. February 2, 1 | 1993-02-02 |
| Triazole angiotensin II antagonists incorporating a substituted benzyl element Grant 5,177,095 - Greenlee , et al. January 5, 1 | 1993-01-05 |
| Angiotensin II antagonists incorporating a substituted indole or dihydroindole Grant 5,175,164 - Bagley , et al. December 29, 1 | 1992-12-29 |
| Substituted 1-(2H)-isoquinolinones bearing acidic functional groups as angiotensin II antagonists Grant 5,162,340 - Chakravarty , et al. November 10, 1 | 1992-11-10 |
| Imidazole angiotensin II antagonists incorporating acidic functional groups Grant 5,126,342 - Chakravarty , et al. June 30, 1 | 1992-06-30 |
| Substituted pyrollo-fused 6 membered heterocycles as angiotensin II antagonists Grant 5,124,335 - Patchett , et al. June 23, 1 | 1992-06-23 |
| HIV reverse transcriptase Grant 5,124,327 - Greenlee , et al. June 23, 1 | 1992-06-23 |
| Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists Grant 5,102,880 - Chakravarty , et al. April 7, 1 | 1992-04-07 |
| Substituted pyrimidinones as angiotensin II antagonists Grant 5,100,897 - Allen , et al. March 31, 1 | 1992-03-31 |
| Angiotensin II antagonists Grant 5,064,825 - Chakravarty , et al. November 12, 1 | 1991-11-12 |
| Antihypertensive proline derivatives Grant 4,402,969 - Greenlee , et al. September 6, 1 | 1983-09-06 |
| Substituted phosphonamides as antihypertensives Grant 4,379,146 - Greenlee , et al. April 5, 1 | 1983-04-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 